This report provides detailed analysis of worldwide markets for Penehyclidine Hydrochloride from 2011-2016, and provides extensive market forecasts (2016-2021) by region/country and subsectors. It covers the key technological and market trends in the Penehyclidine Hydrochloride market and further lays out an analysis of the factors influencing the supply/demand for Penehyclidine Hydrochloride, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

Penehyclidine hydrochloride (PHC), a new anticholinergic drug, was invented by the Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences in China. Its structure is 3-(2-hydroxyl-2-cyclopentyl-2-phenyl-ethoxy) quinuclidine. PHC was commonly applied in clinics as an antagonist of organic phosphorus poisoning and an anaesthetic premedication at present. Animal studies showed that PHC has anti-inflammatory and antioxidant effects on various organs. It is reported that PHC could improve liver function during cardiopulmonary bypass (CPB). The findings confirmed significant protection by PHC against lipopolysaccharide (LPS)-induced lung vascular leak and inflammation in the management of acute lung injury (ALI). In addition, it has been shown that PHC could alleviate lung injuries by inhibiting apoptosis of lung tissue cells. Recently, several studies demonstrated that PHC could improve PaO2/FiO2, decrease pulmonary microvascular permeability, IL-6 levels and MPO activity through the inhibition of extracellular signal-regulated kinase (ERK1/2) and p38 MAPK activation in septic mice.

Browse Full Research Report With TOC:

Report has been prepared based on the synthesis, analysis, and interpretation of information about the global Penehyclidine Hydrochloride market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Penehyclidine Hydrochloride market are Chengdu List Pharmaceutical.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Penehyclidine Hydrochloride industry has been provided.

See More Reports of This Category by Radiant Insights:

About Radiant Insights,Inc
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
28 2nd Street, Suite 3036, San Francisco, CA 94105, United States
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s